47 related articles for article (PubMed ID: 34465658)
1. Long-Term Results of Oral Propranolol Treatment Protocol for Periocular Infantile Hemangioma: Should There Be Any Contraindication?
Ghahvehchian H; Kashkouli MB; Ghanbari S; Karimi N; Abdolalizadeh P; Abri Aghdam K
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):61-69. PubMed ID: 38241619
[TBL] [Abstract][Full Text] [Related]
2. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.
Ji Y; Chen S; Wang Q; Xiang B; Xu Z; Zhong L; Yang K; Lu G; Qiu L
Sci Rep; 2018 Mar; 8(1):4264. PubMed ID: 29523832
[TBL] [Abstract][Full Text] [Related]
3. Excessively High Chronic Propranolol Overdose in Infantile Hemangioma: A Case Report.
Alshammari H; Alessa A; Elsharawy Y; Alghanem A; Alhammad AM
Am J Case Rep; 2023 Nov; 24():e941765. PubMed ID: 38008932
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study.
Wang L; Wang W; Zhou Z; Li J; Li Z; Lv R; Xu G; Bi J; Huo R
J Am Acad Dermatol; 2024 Apr; 90(4):783-789. PubMed ID: 38159645
[TBL] [Abstract][Full Text] [Related]
5. When to stop propranolol for infantile hemangioma.
Chang L; Gu Y; Yu Z; Ying H; Qiu Y; Ma G; Chen H; Jin Y; Lin X
Sci Rep; 2017 Feb; 7():43292. PubMed ID: 28225076
[TBL] [Abstract][Full Text] [Related]
6. Cardiac side effects of propranolol in infants treated for infantile haemangiomas.
Maliqari N; Duka E; Kuneshka L
Cardiol Young; 2023 Dec; 33(12):2616-2620. PubMed ID: 37078179
[TBL] [Abstract][Full Text] [Related]
7. Oral atenolol compared to oral propranolol for infantile hemangioma.
Meza Viteri V; Aranibar L
Medwave; 2023 Dec; 23(11):e2753. PubMed ID: 38061014
[TBL] [Abstract][Full Text] [Related]
8. Tackling the global problem of traumatic stress in low-income countries: a pilot clinical trial comparing reconsolidation therapy to paroxetine in Nepal.
Brunet A; Sapkota RP; Guragain B; Tremblay J; Saumier D; Kirmayer LJ
BMC Psychiatry; 2021 Sep; 21(1):434. PubMed ID: 34479508
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma.
Makkeyah SM; Elseedawy ME; Abdel-Kader HM; Mokhtar GM; Ragab IA
Pediatr Hematol Oncol; 2022 Apr; 39(3):215-224. PubMed ID: 34477031
[TBL] [Abstract][Full Text] [Related]
10. A national audit of oral propranolol for the treatment of infantile haemangiomas.
Cotter C; Solman L; Flohr C
Br J Dermatol; 2022 Jan; 186(1):189-191. PubMed ID: 34473344
[No Abstract] [Full Text] [Related]
11. Infantile Hemangioma Treated with Oral Propranolol: Case Presentation.
Raufi N; Nemat A
Clin Cosmet Investig Dermatol; 2021; 14():1053-1055. PubMed ID: 34471369
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns (Case reports).
Cîrstoveanu C; Bizubac AM; Mustea C; Manolache Ș; Istrate-Bârzan A; Sfrijan D; Marcu V; Iozsa DA; Spătaru RI
Exp Ther Med; 2021 Oct; 22(4):1097. PubMed ID: 34504551
[TBL] [Abstract][Full Text] [Related]
13. From clinical trials to clinical practice: the use of everolimus and exemestane in the treatment of hormone receptor-positive metastatic breast cancer: real-world data.
Abdel-Razeq H; Sharaf B; Abdulelah H; Abdel-Razeq N; Salam M; Inserat B; Bater R
J Chemother; 2022 May; 34(3):184-189. PubMed ID: 34486957
[TBL] [Abstract][Full Text] [Related]
14. Measuring the impact of clinical practice guidelines on infantile hemangioma referrals.
Barton MT; Latour E; Small A; Leitenberger S; Funk T
Pediatr Dermatol; 2021 Sep; 38(5):1393-1395. PubMed ID: 34467544
[TBL] [Abstract][Full Text] [Related]
15. The impact of propranolol on the growth and development of children with proliferative infantile hemangioma during treatment.
Lin X; Wang T; Liu C; Deng L; Wang Q; Huang L; Gao J; Chen X; Chen S
Medicine (Baltimore); 2023 Jun; 102(23):e33998. PubMed ID: 37335657
[TBL] [Abstract][Full Text] [Related]
16. Propranolol in the Treatment of Infantile Hemangiomas.
Tan X; Guo S; Wang C
Clin Cosmet Investig Dermatol; 2021; 14():1155-1163. PubMed ID: 34511960
[TBL] [Abstract][Full Text] [Related]
17. Adverse Drug Reactions Following Propranolol in Infantile Hemangioma.
Pandey V; Tiwari P; Imran M; Mishra A; Kumar D; Sharma SP
Indian Pediatr; 2021 Aug; 58(8):753-755. PubMed ID: 34465658
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of propranolol therapy in 109 infants with infantile hemangioma.
Gan LQ; Ni SL; Tan Q; Wang H
Pediatr Dermatol; 2013; 30(2):270-2. PubMed ID: 23252446
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
